WFH NETWORK

Congress News

Congress Daily Online 

The official online news source for the WFH 2018 World Congress

Read articles on Congress Daily Online >

 


WFH 2018 World Congress - Sponsor News

WALTHAM, Mass. – May 21, 2018
Bioverativ Presents Preliminary Phase 1/2a Data on BIVV001, the First Factor VIII Therapy to Break Through the VWF Half-life Ceiling in Hemophilia A. Download the PDF >

© World Federation of Hemophilia